Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 02012D0715-20130515

    Consolidated text: Commission Implementing Decision of 22 November 2012 establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council (Text with EEA relevance) (2012/715/EU)

    ELI: http://data.europa.eu/eli/dec_impl/2012/715/2013-05-15

    2012D0715 — EN — 15.05.2013 — 001.001


    This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

    ►B

    COMMISSION IMPLEMENTING DECISION

    of 22 November 2012

    establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council

    (Text with EEA relevance)

    (2012/715/EU)

    (OJ L 325, 23.11.2012, p.15)

    Amended by:

     

     

    Official Journal

      No

    page

    date

    ►M1

    COMMISSION IMPLEMENTING DECISION of 24 April 2013

      L 113

    22

    25.4.2013




    ▼B

    COMMISSION IMPLEMENTING DECISION

    of 22 November 2012

    establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council

    (Text with EEA relevance)

    (2012/715/EU)



    THE EUROPEAN COMMISSION,

    Having regard to the Treaty on the Functioning of the European Union,

    Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to medicinal products for human use ( 1 ), and in particular Article 111b(1) thereof,

    Whereas:

    (1)

    In accordance with Article 111b(1) of Directive 2001/83/EC a third country may request the Commission to assess whether its regulatory framework applicable to active substances exported to the Union and the respective control and enforcement activities ensure a level of protection of public health equivalent to that of the Union in order to be included in a list of third countries ensuring an equivalent level of protection of public health.

    (2)

    Switzerland requested, by letter dated 4 April 2012, to be listed in accordance with Article 111b(1) of Directive 2001/83/EC. The equivalence assessment by the Commission confirmed that the requirements of that Article were fulfilled. In exercising this equivalence assessment, account was taken of the agreement on mutual recognition ( 2 ) as referred to in Article 51(2) of that Directive between Switzerland and the Union,

    HAS ADOPTED THIS DECISION:



    Article 1

    The list of third countries referred to in Article 111b(1) of Directive 2001/83/EC is set out in the Annex to this Decision.

    Article 2

    This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

    ▼M1




    ANNEX



    Third country

    Remarks

    Australia

     

    Switzerland

     



    ( 1 ) OJ L 311, 28.11.2001, p. 67.

    ( 2 ) OJ L 114, 30.4.2002, p. 369.

    Top